The Vizient Summer 2025 Spend Management Outlook (SMO) provides an integrated perspective on trends, factors and future expenses providers will face across the various dimensions of healthcare. In this episode, Dr. Carina Dolan and Dr. Jeni Hayes join host Carolyn Liptak to discuss pharmacy insights from the SMO including declining drug price inflation and how autoimmune conditions have surpassed oncology in total pharmacy costs. They also touch on pediatric spend drivers, biosimilar competition, and the impact of novel therapies. Tune in to VerifiedRx for practical insights to help pharmacy leaders plan for what’s ahead.

Guest speakers:

Carina Dolan, Pharm. D., MS Pharm, BCOP Associate Vice President, Clinical Oncology, Pharmacoeconomics and Market Insights Vizient Jeni Hayes, PharmD, MS Pharm, BCPS Senior Clinical Manager, Market Intelligence Vizient  Host:  Carolyn Liptak, BS Pharm, MBA VerifiedRx Host

Show Notes:

[01:13-02:41] Key pharmacy trends emerging from the Summer SMO

[02:42-04:00] Current pharmacy trends

[04:01-05:55] Pharmacy spend for autoimmune conditions has exceeded that of oncology

[05:56-07:36] Key takeaways

[07:37-08:47] Significant trends in this latest therapeutic insights update

[08:48-10:04] Challenges in gene and cell therapy space

[10:05-11:33] The Therapeutic Insights webpage for pediatrics

[11:34-13:41] Other reflections from the SMO

[13:42-14:49] How to locate the SMO

Links | Resources:

Vizient Spend Management Outlook

Vizient Therapeutic class insights

Subscribe Today!

Apple Podcasts

Amazon Podcasts

Spotify

Android

RSS Feed